PROC
Sofgen Pharma SA
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · LU
$1.01
+0.00%Latest reported
- Last report date
- Dec 31, 2024
- EPS actual
- $0.08
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +173.5%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Dec 31, 2024 | — | $0.08 | — | — |
| Feb 28, 2024 | $0.09 | $0.09 | In line | $110.6M |
| Sep 5, 2023 | $0.06 | $0.27 | Beat 350.00% | $110.1M |
| Jun 5, 2023 | $0.02 | $0.07 | Beat 274.93% | $84.2M |
| Nov 14, 2022 | $0.13 | $0.22 | Beat 69.23% | $110.4M |
| Aug 30, 2022 | $0.13 | -$0.07 | Miss -153.85% | $112.4M |
| Jun 15, 2022 | $0.09 | $0.16 | Beat 80.78% | $85.6M |
| Oct 6, 2021 | — | -$0.01 | — | $98.9M |
| Sep 30, 2021 | — | -$0.38 | — | $106.8M |
| Mar 30, 2019 | — | -$0.04 | — | $81.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 31, 2024